Day: February 28, 2017

The tale of bird flu, a Derbyshire company and MILLIONS of labels

Positive ID Labelling is producing ‘millions’ of labels telling consumers about measures that have been taken to prevent to spread of avian bird flu among UK hen flocks. A Derbyshire firm has been tasked with printing millions of labels that have started to appear on egg boxes informing consumers about measures taken to minimise the risk of avian bird flu spreading in the UK.

Hordes of people wasting NHS resources for allergy tests

Are we a nation of hypochondriacs? Majority of people wasting NHS resources on allergy tests they DON’T need, experts say Roughly 12 per cent of the adult population believe they have a food aversion – when, in reality, only 1 to 2 per cent actually do. The latter, although only comprising of four questions, offered a 90 per cent accuracy in detection and could subsequently help save the NHS huge sums.

Achillion Pharmaceuticals to Support a Natural History Study of C3…

Achillion Pharmaceuticals to Support a Natural History Study of C3 Glomerulopathy, a Rare Renal Disorder, Conducted by Experts at Imperial College London Natural history studies track course of a disease over time; can inform and support development and approval of new treatments for patients C3 glomerulopathy currently has no cure or approved treatment; affects about 8,000 people across Europe and the United States NEW HAVEN, Conn., Feb. 28, 2017 — Achillion Pharmaceuticals, Inc. announced that it has entered into an agreement with Imperial College London to conduct a natural history study of C3 glomerulopathy , a rare renal disorder which includes dense deposit disease and C3 glomerulonephritis .

More

Representative David Rouzer is weighing in on the proposed health care legislation in Congress that would replace Obamacare. Republican leadership introduced the bill earlier this week.

BIDMC scientists discover vulnerability that offers new strategy to…

Physicians currently have no targeted treatment options available for women diagnosed with an aggressive form of breast cancer known as triple-negative breast cancer , leaving standard-of-care chemotherapies as a first line of defense against the disease. However, most women with TNBC do not respond to these broadly-targeted chemotherapies, and those who do often develop resistance to the drugs.

Nicky Heath of the Yeleni Centre

A CARE company and complementary therapy centre in Hereford are joining forces to host a wellbeing day to raise funds for charity. The event, being organised by Kemble at Home and the Yeleni Therapy and Support Centre, will include a range of workshops and therapy experiences aimed at supporting general health and wellbeing – all for donations to the charity.

VDMC to hold seminar

The Senior Health Insurance Information Program and the SHIIP counselors at Van Diest Medical Center are offering a free seminar Thursday, March 30 beginning at 5:30 p.m. The seminar is designed for those who eligible for Medicare in the near future or those who have been on Medicare and want to better understand what it offers. The seminar will be held in the Clinic Board Room located in the Van Diest Family Health Clinic.

WHO issues warning over superbugs

Superbugs which cause sepsis, pneumonia, and salmonella will soon be resistant to antibiotics, the World Health Organisation has warned as it called on governments to stop relying on pharmaceutical companies to solve the crisis. Health officials have drawn up a list of 12 types of bacteria which pose the “greatest threat to human health” because soon no drugs will be able to fight them off.

Study highlights urgent need for sunburn prevention among young adults with melanin-rich skin

Results from a study published in The Journal of the American Osteopathic Association point to an urgent need for sunburn prevention among young adults, particularly those who have skin with higher melanin content. Researchers found a surprising correlation between reporting a red or painful sunburn lasting a day or more with being 18 to 29 years of age and not self-identifying as white.

SBP researchers identify new regulator of innate immune response to foreign invaders

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a new regulator of the innate immune response – the immediate, natural immune response to foreign invaders. The study, published recently in Nature Microbiology , suggests that therapeutics that modulate the regulator – an immune checkpoint – may represent the next generation of antiviral drugs, vaccine adjuvants, cancer immunotherapies, and treatments for autoimmune disease.